The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 13 rounds in the feed, most often at Series B and in Biotech.
Venture capitalcasdincapital.comRounds from 2018-05-07 to 2026-10-06
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Multiply Labs Multiply Labs develops robotic systems that automate manual steps in biologics manufacturing, making advanced therapies more accessible. | Series B Verified against 4 of 31 sources | $75M | 2026-10-06 | [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series C |
| $85M |
| 2026-06-30 |
| [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $123M | 2023-03-22 | [ PART ] |
Thyme Care Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes, and costs. | Funding round Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $22M | 2021-10-05 | [ PART ] |
Hexagon Bio A biopharmaceutical company pioneering the discovery of novel payload mechanisms for antibody-drug conjugates (ADCs) | Funding round Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $61M | 2021-09-22 | [ PART ] |
Umoja Biopharma Umoja Biopharma, a clinical-stage leader developing in vivo CAR T cell therapies. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $210M | 2021-06-15 | [ PART ] |
LetsGetChecked LetsGetChecked sells at-home health tests, telehealth services, and pharmacy solutions to individuals and businesses. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2021-06-08 | [ LEAD ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $82M | 2021-05-13 | [ PART ] |
Multiply Labs Multiply Labs develops robotic systems that automate manual steps in biologics manufacturing, making advanced therapies more accessible. | Series A Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $20M | 2021-04-14 | [ LEAD ] |
Komodo Health Komodo Health sells AI-driven healthcare analytics solutions that provide comprehensive, de-identified patient-level data for healthcare organizations and life sciences companies. | Series E Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $220M | 2021-03-22 | [ PART ] |
Lyra Health Lyra Health sells mental health care services using AI-powered platforms to connect individuals with qualified providers across various sectors. | Series D Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $110M | 2020-08-25 | [ PART ] |
Lyra Health Lyra Health sells mental health care services using AI-powered platforms to connect individuals with qualified providers across various sectors. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $75M | 2020-03-11 | [ PART ] |
Lyra Health Lyra Health sells mental health care services using AI-powered platforms to connect individuals with qualified providers across various sectors. | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $45M | 2018-05-07 | [ PART ] |